These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27583170)

  • 1. Biparametric versus multiparametric MRI in the diagnosis of prostate cancer.
    Thestrup KC; Logager V; Baslev I; Møller JM; Hansen RH; Thomsen HS
    Acta Radiol Open; 2016 Aug; 5(8):2058460116663046. PubMed ID: 27583170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric Magnetic Resonance Imaging in Evaluation of Clinically Significant Prostate Cancer.
    Ingole SM; Mehta RU; Kazi ZN; Bhuyar RV
    Indian J Radiol Imaging; 2021 Jan; 31(1):65-77. PubMed ID: 34316113
    [No Abstract]   [Full Text] [Related]  

  • 4. Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.
    Kuhl CK; Bruhn R; Krämer N; Nebelung S; Heidenreich A; Schrading S
    Radiology; 2017 Nov; 285(2):493-505. PubMed ID: 28727544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI of the prostate with three functional techniques in patients with PSA elevation before initial TRUS-guided biopsy.
    Hauth E; Hohmuth H; Cozub-Poetica C; Bernand S; Beer M; Jaeger H
    Br J Radiol; 2015 Oct; 88(1054):20150422. PubMed ID: 26268144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the most optimal multiparametric magnetic resonance imaging sequence for determining pathological length of capsular contact.
    Onay A; Vural M; Armutlu A; Ozel Yıldız S; Kiremit MC; Esen T; Bakır B
    Eur J Radiol; 2019 Mar; 112():192-199. PubMed ID: 30777210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach.
    Delli Pizzi A; Mastrodicasa D; Marchioni M; Primiceri G; Di Fabio F; Cianci R; Seccia B; Sessa B; Mincuzzi E; Romanelli M; Castellan P; Castellucci R; Colasante A; Schips L; Basilico R; Caulo M
    Eur Radiol; 2021 Jun; 31(6):3874-3883. PubMed ID: 33211143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized MRI Assessment for Clinically Significant Prostate Cancer: A STARD-Compliant Two-Center Study.
    Bao J; Zhi R; Hou Y; Zhang J; Wu CJ; Wang XM; Zhang YD
    J Magn Reson Imaging; 2021 Apr; 53(4):1210-1219. PubMed ID: 33075177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.
    Abd-Alazeez M; Ramachandran N; Dikaios N; Ahmed HU; Emberton M; Kirkham A; Arya M; Taylor S; Halligan S; Punwani S
    Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):128-36. PubMed ID: 25644248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
    Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
    Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.
    Rosenkrantz AB; Kim S; Campbell N; Gaing B; Deng FM; Taneja SS
    AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
    Krishna S; McInnes M; Lim C; Lim R; Hakim SW; Flood TA; Schieda N
    AJR Am J Roentgenol; 2017 Dec; 209(6):W365-W373. PubMed ID: 28981356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of biparametric MRI to full multiparametric MRI for detection of clinically significant prostate cancer.
    Sherrer RL; Glaser ZA; Gordetsky JB; Nix JW; Porter KK; Rais-Bahrami S
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):331-336. PubMed ID: 30413806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI).
    Gatti M; Faletti R; Calleris G; Giglio J; Berzovini C; Gentile F; Marra G; Misischi F; Molinaro L; Bergamasco L; Gontero P; Papotti M; Fonio P
    Abdom Radiol (NY); 2019 May; 44(5):1883-1893. PubMed ID: 30788558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
    Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
    Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
    Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
    Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
    Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
    Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
    Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
    Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biparametric (bp) and multiparametric (mp) magnetic resonance imaging (MRI) approach to prostate cancer disease: a narrative review of current debate on dynamic contrast enhancement.
    Palumbo P; Manetta R; Izzo A; Bruno F; Arrigoni F; De Filippo M; Splendiani A; Di Cesare E; Masciocchi C; Barile A
    Gland Surg; 2020 Dec; 9(6):2235-2247. PubMed ID: 33447576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the diagnostic accuracy and validity of biparametric MRI and multiparametric MRI-based VI-RADS scoring in bladder cancer; is contrast material really necessary in detecting muscle invasion?
    Aslan S; Cakir IM; Oguz U; Bekci T; Demirelli E
    Abdom Radiol (NY); 2022 Feb; 47(2):771-780. PubMed ID: 34919161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.